nasal
decongest
oxymetazolin
omz
exhibit
antioxid
antiinflammatori
properti
beckspeier
et
al
j
pharmacol
exp
ther
follow
studi
hypothes
omz
gener
proresolv
lipoxin
parallel
product
immunemodul
prostaglandin
antiinflammatori
hydroxyeicosatetraeno
acid
hete
deplet
proinflammatori
leukotrien
ltb
human
neutrophil
pmn
chosen
cellular
system
effect
omz
paramet
well
respiratori
burst
activ
oxid
stress
marker
analyz
unstimul
costimul
pmn
ultrafin
carbon
particl
ucp
opson
zymosan
oz
respect
unstimul
cell
omz
induc
format
pge
hete
level
affect
wherea
respiratori
burst
activ
drastic
inhibit
ucpand
ozstimul
control
cell
paramet
elev
omz
maintain
increas
level
pge
hete
substanti
suppress
level
inhibit
respiratori
burst
activ
find
suggest
switch
proinflammatori
eicosanoid
class
ltb
proresolv
lxa
sinc
lxa
relev
return
inflam
tissu
homeostasi
omz
postul
termin
rhinitisrel
inflamm
thu
contribut
shorten
diseas
durat
upper
respiratori
tract
infect
urti
mainli
caus
rhinovirus
lead
profound
econom
disprofit
due
medic
expens
loss
product
moreov
complic
rhinoviru
induc
urti
includ
otiti
media
sinus
well
exacerb
lower
respiratori
tract
diseas
exampl
asthma
chronic
obstruct
pulmonari
diseas
copd
enorm
impact
upon
health
care
symptomat
therapi
urti
also
known
common
cold
effect
carri
applic
nasal
decongest
oxymetazolin
omz
nearli
year
omz
sympathomimet
imidazolin
deriv
direct
alphaadrenerg
activ
vascular
smooth
muscl
cell
nasal
mucosa
lead
vasoconstrict
onset
action
within
second
last
twelv
hour
addit
symptomat
effect
recent
studi
also
document
antioxid
antiinflammatori
properti
omz
et
al
show
antiinflammatori
action
omz
partial
mediat
inhibit
proinflammatori
cytokin
tumor
necrosi
well
reduc
tcell
stimulatori
capac
dendrit
cell
result
repress
stimul
cell
westerveld
et
al
show
omz
potent
inhibitor
microsom
lipid
peroxid
hydroxyl
radic
scaveng
furthermor
recent
report
omz
exhibit
antioxid
antiinflammatori
properti
cellfre
system
well
cellular
system
consist
canin
alveolar
macrophag
omz
found
clearli
inhibit
proinflammatori
reaction
respiratori
burst
pathway
format
leukotrien
b
ltb
besid
drug
capabl
induc
cyclooxygenas
cox
pathway
format
immunemodul
prostaglandin
e
pge
pathway
product
antiinflammatori
hydroxyeicosatetraeno
acid
hete
protect
process
known
trigger
pathway
involv
resolut
inflamm
resolut
inflamm
activ
process
format
call
stop
signal
newli
discov
antiinflammatori
proresolv
dual
function
mediat
lipoxin
lxa
lipoxin
b
lxb
view
immunemodul
antiinflammatori
properti
omz
hypothes
omz
potenti
induc
gener
lipoxin
turn
contribut
resolut
phase
inflamm
resolut
phase
inflamm
import
event
return
inflam
tissu
homeostasi
complet
resolut
without
leav
molecular
sign
trace
leukocyt
battl
otherwis
chronic
inflammatori
process
may
occur
infect
rhinovirus
induc
inflammatori
reaction
influx
polymorphonuclear
neutrophil
pmn
nasal
tissu
cell
serv
model
studi
omz
suggest
omz
abl
induc
immunemodul
pge
antiinflammatori
inhibit
proinflammatori
ltb
due
activ
inhibit
lipid
mediat
correspond
enzym
switch
eicosanoid
may
occur
omz
result
inhibit
ltb
format
activ
pge
synthesi
hete
gener
lead
product
proresolv
lxa
phosphatebuff
salin
pb
without
ca
mg
purchas
biochrom
berlin
germani
luminol
zymosan
sigma
deisenhofen
germani
solut
omz
suspens
ultrafin
carbon
particl
opson
zymosan
omz
merck
darmstadt
germani
dissolv
dilut
pb
ca
mg
ph
contain
glucos
ultrafin
carbon
particl
ucp
gener
spark
discharg
suspend
distil
water
repeat
vortex
sonif
opson
zymosan
prepar
zymosan
purifi
heat
min
steril
nacl
solut
incub
freshfrozen
human
serum
equalvolum
portion
min
room
temperatur
accord
allen
wash
opson
zymosan
suspend
pb
ph
contain
glucos
pmn
isol
citrateanticoagul
venou
blood
healthi
human
volunt
polymorphprep
axisshield
oslo
norway
accord
beckspeier
et
al
briefli
isol
layer
pmn
wash
pb
ph
without
ca
mg
remov
gradient
medium
residu
erythrocyt
lyse
treat
cell
pellet
distil
water
isoton
restor
ad
volum
w
v
nacl
purifi
cell
resuspend
pb
ph
ca
mg
glucos
viabil
cell
alway
determin
trypan
blue
exclus
cell
identifi
microscop
examin
cytospin
prepar
may
giemsa
stain
popul
pmn
prove
effect
omz
viabil
cell
pmn
incub
variou
omz
concentr
mm
pb
ph
ca
mg
glucos
absenc
stimul
min
harvest
cell
centrifug
g
min
room
temperatur
cell
resuspend
hepe
buffer
ph
contain
mm
edta
aliquot
cell
suspens
use
determin
viabil
trypan
blue
exclus
effect
omz
pmn
determin
absenc
presenc
costimulatori
agent
ultrafin
element
carbon
particl
ucp
opson
zymosan
oz
stimul
particul
ingest
phagocyt
cell
ucp
via
nonreceptormedi
phagocytosi
oz
via
receptormedi
phagocytosi
follow
treatment
perform
accord
previou
studi
assess
effect
omz
unstimul
cell
pmn
ml
incub
variou
concentr
omz
mm
correspond
respect
pb
ph
ca
mg
glucos
min
ii
measur
effect
omz
stimul
cell
pmn
cell
ml
incub
parallel
incub
variou
concentr
omz
mm
pb
ph
ca
mg
glucos
min
subsequ
costimul
ucp
ml
oz
addit
min
incub
procedur
cell
harvest
centrifug
g
min
room
temperatur
cell
resuspend
cold
hepe
buffer
ph
contain
mm
edta
homogen
sonif
time
time
ice
centrifug
g
min
importantli
cell
kept
ice
prepar
avoid
activ
degrad
process
supernat
taken
analysi
protein
lipid
mediat
analysi
lysat
reliabl
tool
quantifi
eicosanoid
product
favor
analysi
extracellular
level
sensit
intracellular
approach
support
normal
eicosanoid
level
protein
content
lysat
analysi
cellular
eicosanoid
content
appear
relev
regard
autocrin
mechan
pge
might
trigger
function
metabol
paramet
pmn
protein
measur
nm
microtit
plate
format
use
cell
homogen
dilut
biorad
solut
biorad
munich
germani
bovin
serum
albumin
standard
analysi
lipid
mediat
supernat
cell
homogen
deprotein
ad
volum
methanol
contain
mm
edta
mm
ph
methanol
suspens
store
h
follow
two
centrifug
step
g
min
interv
remov
protein
aliquot
obtain
supernat
dri
vacuum
centrifug
dissolv
assay
buffer
use
quantif
pge
ltb
hete
lxa
measur
specif
enzym
immunoassay
cayman
chemic
accord
instruct
manufactur
respiratori
burst
activ
human
pmn
determin
luminoldepend
chemiluminesc
cl
accord
mishra
et
al
briefli
pmn
cell
preincub
ml
pb
ph
contain
ca
mg
glucos
mm
luminol
min
chemiluminesc
analyz
autoluminat
lb
berthold
technolog
bad
wildbad
germani
cl
signal
pmn
absenc
presenc
variou
omz
concentr
record
min
thereaft
ucp
oz
respect
ad
cl
signal
cell
monitor
min
statist
signific
determin
analysi
varianc
twosampl
student
ttest
statsak
version
ge
dallal
malden
usa
chang
consid
signific
effect
omz
viabil
cell
evalu
trypan
blue
exclus
percentag
basi
shown
fig
omz
affect
viabil
pmn
differ
dead
live
cell
untreat
pmn
mm
omztreat
pmn
mm
signific
data
indic
omz
exert
toxic
effect
pmn
human
pmn
studi
effect
omz
absenc
presenc
costimul
follow
endpoint
analyz
format
pge
hete
lxa
b
format
concentr
rang
mm
omz
exert
signific
stimulatori
effect
format
pge
hete
lxa
unstimul
pmn
fig
format
ltb
oxid
stress
marker
affect
omz
fig
contrast
respiratori
burst
activ
strongli
inhibit
concentr
mm
omz
baselin
level
fig
ucp
select
model
stimul
particl
known
induc
format
pge
hete
lxa
ltb
respiratori
burst
activ
shown
fig
ucp
appli
absenc
omz
ucp
control
activ
pmn
signific
increas
level
paramet
p
comparison
respect
baselin
level
omz
exert
differenti
effect
ucpinduc
respons
omz
substanti
chang
elev
ucpstimul
level
pge
hete
lxa
fig
howev
increas
level
ucpstimul
ltb
drastic
suppress
concentr
mm
omz
wherea
respiratori
burst
activ
significantli
inhibit
omz
concentr
mm
fig
addit
environment
costimul
ucp
nonphysiolog
also
use
oz
physiolog
costimul
opson
complement
compon
ucp
oz
particul
stimuli
induc
inflammatori
oxid
stress
reaction
howev
oz
opson
elicit
stronger
biolog
respons
ucp
especi
concern
ltb
respiratori
burst
activ
shown
fig
oz
control
stimul
induc
format
pge
hete
lxa
ltb
activ
respiratori
burst
activ
p
alreadi
seen
ucp
omz
exert
differ
effect
ozinduc
respons
omz
essenti
chang
ozstimul
elev
pge
hete
lxa
level
fig
howev
increas
level
ozstimul
ltb
respiratori
burst
activ
drastic
inhibit
omz
nearli
baselin
level
fig
ltb
level
respiratori
burst
activ
reduc
omz
concentr
mm
wherea
oxid
stress
marker
inhibit
omz
concentr
rang
mm
previou
studi
show
vitro
assay
omz
inhibit
activ
proinflammatori
properti
activ
show
antiinflammatori
characterist
inhibit
use
canin
alveolar
macrophag
cellular
model
recent
confirm
omz
inhibit
pathway
caus
decreas
product
ltb
induc
pathway
result
increas
hete
gener
present
studi
design
investig
effect
omz
eicosanoid
metabol
human
pmn
repres
major
popul
inflammatori
cell
virusinfect
nasal
tissu
base
observ
omz
activ
pathway
postul
omz
also
induc
format
proresolv
lipoxin
final
metabolit
pathway
studi
perform
unstimul
pmn
pmn
stimul
ucp
oz
simul
inflammatori
respons
oxid
stress
data
demonstr
omz
inhibit
respiratori
burst
activ
effici
baselin
level
ltb
use
oxid
stress
marker
affect
unstimul
pmn
howev
immunemodul
antiinflammatori
respons
includ
pge
hete
proresolv
mediat
lxa
product
significantli
increas
ucpor
ozstimul
cell
omz
strongli
inhibit
ltb
format
respiratori
burst
activ
increas
level
pge
hete
lxa
reach
stimul
maintain
presenc
omz
suppos
ucpand
ozstimul
cell
upper
limit
produc
pge
hete
lxa
allow
increas
omz
vitro
condit
similar
respons
regard
pge
hete
ltb
respiratori
burst
activ
alreadi
observ
canin
react
similar
human
effect
concentr
omz
inhibit
proinflammatori
oxid
stress
reaction
pmn
rang
mm
omz
concentr
also
shown
relev
previou
studi
estim
omz
current
product
concentr
mm
nose
spray
adult
school
children
dosag
volum
dilut
form
concentr
gradient
rang
level
omz
use
experi
estim
mean
valu
almost
equal
mm
therefor
present
result
relev
situ
howev
still
unknown
receptor
omz
modul
inflamm
possibl
omz
exert
effect
lipid
mediat
via
andor
adrenoceptor
sinc
studi
stabli
transfect
chines
hamster
ovari
cho
cell
shown
omz
behav
partial
agonist
adrenoceptor
also
observ
adrenoceptor
addit
low
precis
measur
agonist
activ
omz
observ
transfect
cho
cell
express
adrenoceptor
viral
infect
induc
strong
inflamm
nasal
tissu
lead
acut
rhiniti
inflammatori
mediat
play
import
role
pathogenesi
acut
rhiniti
nasal
secret
becom
enrich
proinflammatori
mediat
cytokin
eicosanoid
leukotrien
prostaglandin
accompani
infiltr
pmn
ltb
potent
chemoattract
pmn
therefor
respons
neutrophil
infiltr
rhinitisinfect
tissu
data
vitro
approach
demonstr
omz
inhibit
product
ltb
releas
reactiv
oxygen
speci
ro
parallel
substanti
increas
pge
besid
specif
proinflammatori
properti
pge
shown
last
decad
exhibit
predominantli
regulatori
function
control
immun
respons
exampl
attenu
proinflammatori
reaction
one
import
target
cyclooxygenas
metabolit
pathway
inhibit
leukotrien
synthesi
transloc
stimul
pmn
furthermor
pge
found
upregul
express
pmn
activ
pathway
gener
hete
lipoxin
exposur
pmn
hete
also
attenu
level
ltb
substanti
stimul
ca
ionophor
fmlp
peptid
upregul
express
releas
hete
seem
regulatori
mechan
cope
inflamm
evid
express
human
nasal
epithelium
mediat
mucociliari
differenti
express
nasal
epithelium
may
support
find
effect
omz
hete
format
pmn
hete
key
metabolit
gener
lipoxin
also
involv
action
lipoxin
primarili
engag
resolut
termin
inflammatori
event
return
inflam
tissu
homeostasi
although
pge
initi
number
respons
relev
inflamm
central
task
metabolit
trigger
lipid
mediat
class
switch
signal
end
inflamm
activ
transcript
regul
result
product
lxa
sinc
omz
induc
format
pge
hete
indic
activ
reduc
ltb
product
indic
reduct
activ
omz
suggest
substanti
support
switch
eicosanoid
class
ltb
lxa
import
pge
induc
omz
inflammatori
respons
nasal
tissu
emphas
studi
han
et
al
show
nasal
patenc
reduc
cox
activ
inhibit
nonsteroid
antiinflammatori
drug
moreov
respiratori
burst
activ
oxid
stress
induc
ucp
oz
inhibit
omz
inhibit
paramet
might
due
radic
scaveng
activ
omz
propos
westerveld
et
al
omz
contain
hydroxyl
group
phenyl
ring
abl
easili
provid
hydrogen
atom
reaction
lipid
peroxiderel
radic
reactiv
oxygen
speci
due
radic
scaveng
activ
suggest
omz
also
neutral
radic
aris
respiratori
burst
activ
abolish
ucpand
ozinduc
format
repres
protect
mechan
avoid
excess
releas
reactiv
omz
interfer
neutrophil
membran
activ
cytoplasmat
phospholipas
liber
arachidon
acid
membran
phospholipid
arachidon
acid
metabol
immunemodul
cyclooxygenas
cox
antiinflammatori
act
hete
contrast
hete
omz
inhibit
initi
enzym
leukotrien
synthesi
result
reduc
product
proinflammatori
furthermor
omz
inhibit
respiratori
burst
activ
nadph
oxidas
lead
diminish
product
tissuedamag
reactiv
oxygen
speci
ro
thu
intensifi
inhibitori
effect
proinflammatori
reaction
presenc
environment
physiolog
stimuli
ultrafin
carbon
particl
ucp
opson
zymosan
oz
omz
also
inhibit
synthesi
respiratori
burst
activ
wherea
hete
product
affect
addit
omz
prevent
format
oxid
stress
marker
induc
oxid
capac
environment
particl
opson
zymosan
due
inhibit
format
induct
hete
product
omz
abl
switch
eicosanoid
class
proinflammatori
proresolv
highlight
antiinflammatori
proresolv
role
omz
rhiniti
oxygen
speci
tissu
damag
principl
elev
level
lxa
trigger
omz
may
also
contribut
shorten
durat
diseas
prospect
multicent
random
placebocontrol
doubleblind
parallel
group
comparison
studi
omz
vs
physiolog
salin
solut
rhiniti
durat
determin
primari
endpoint
commoncold
patient
patient
site
secondari
endpoint
notic
relief
nasal
congest
runni
nose
stuffi
nose
sneez
impair
sens
smell
tast
feel
unwel
maximum
treatment
durat
day
puff
omz
nostril
three
time
daili
symptom
improv
significantli
omz
versu
refer
group
treat
physiolog
salin
solut
earli
treatment
day
relief
maintain
throughout
studi
period
durat
rhiniti
significantli
reduc
onethird
vs
day
omz
summari
propos
omztrigg
signal
cascad
pmn
shown
fig
omz
seem
lead
signal
activ
product
pge
suppress
ltb
format
activ
pathway
concert
action
pge
proresolv
lipid
mediat
lxa
stop
pmn
influx
thu
termin
inflamm
furthermor
lxa
stimul
monocyt
recruit
uptak
apoptot
pmn
macrophag
lxa
relev
capabl
return
inflam
tissu
homeostasi
regard
increas
mainten
lxa
level
omz
may
enhanc
termin
rhinitisrel
inflamm
thu
contribut
significantli
shorten
durat
diseas
